Suchergebnisse - "State Medicine"

PubPharm (2)

1

Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation

in: Health Technology Assessment | 2018

von Steve J Edwards | Victoria Wakefield | Peter Cain | +5

2

Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom

enthalten in: Value in health | 2015

von Kusel, J. | Allen, F. | Adlard, N. | +2

1
[1]